Trials / Completed
CompletedNCT00328705
D2-EPG Study: Evaluation of New Sensing Circuitry and Capture Management
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an acute, prospective, multi-center, non-randomized, investigational device exemption (IDE) clinical study.
Detailed description
The purpose of this study is to confirm the performance of new sensing circuitry, and to confirm the performance of a Ventricular Capture Management feature in subjects with implantable cardioverter defibrillator (ICD) leads connected to an external pacemaker/defibrillator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantable Cardioverter Defibrillator |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2007-01-01
- Completion
- 2007-01-01
- First posted
- 2006-05-22
- Last updated
- 2008-02-13
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00328705. Inclusion in this directory is not an endorsement.